易特科(前海安测)AI慢病干预项目通过验收

2019-06-06 16:12

近日知悉,易特科(前海安测)现代中西医O2O慢病干预技术与服务运营项目于近日正式通过政府科技部门的专家组验收,这意味着易特科(前海安测)圆满完成了研发任务,实现了主要技术指标,慢病管理干预技术再一次获得了专业认可,技术研发实力再上新台阶!


该项目将助力各级医卫机构建立和完善区域体检系统、区域健康管理系统、区域慢病管理系统等,为慢性病重点监管人群、全国居民提供慢性病健康管理服务。该项目成果将现代中西医O2O慢病干预技术向智慧医疗领域延伸应用,进一步提高了健康监测、健康评估、健康干预能力和治疗水平,为积极应对我国主要健康问题和挑战、推动医疗卫生事业全面协调可持续发展、推进健康中国建设提供了有力支撑。

自成立伊始,易特科(前海安测)就重点以健康管理尤其是慢性病管理为突破口,建立专门的研发团队,与海南医学院、南方医科大学、都柏林城市大学等科研机构合作,在首席科学家姚建铨院士的指导下,聚焦疾病评估模型、大数据分析,建立了Anycheck健康管理云平台,通过AI 赋能医疗,探索智慧医疗的创新模式。

近年来,在国家卫健委、市委市政府、深圳市科创委的领导下,易特科(前海安测)始终坚持 “技术引领·创新驱动”,发挥智慧医疗领军企业的作用,勇于创新、先行先试,持续投入信息技术、生物科技、数字技术等领域,以最先进的人工智能、大数据、深度学习等技术和产品服务于医疗信息化、健康养老行业。对此,项目验收专家组给予了充分肯定和高度评价,一致同意该项目通过验收。

易特科集团简介:

易特科集团(前海安测)是一家专业从事生命IT技术研究和产品开发的高新技术企业。2003年创立以来,易特科深耕医疗大健康行业,以尖端技术研究和创新为公司核心发展战略,注重企业文化和品牌建设,持续投入信息技术、生物科技、数字技术等领域,以最先进的人工智能、大数据、深度学习等技术和产品服务于医疗信息化、健康养老行业。

易特科集团总部位于深圳南山科技园数字技术园,在北京、上海、广州、天津、西安、石家庄、福州、沈阳、长沙、桂林等地设有分部,并在美国硅谷、欧洲爱尔兰和芬兰和中国香港等地设有海外分支机构。目前,医疗智能化、智能检测设备、医疗信息化、健康信息化、区域卫生信息化等产品和解决方案入选国家工信部产品服务推广目录,并广泛应用于全国650多家三甲医院、二甲医院以及450家社康中心和健康管理中心,得到了市场的积极响应和广泛好评。

多年来,易特科一直秉承“创新驱动·技术引领”的经营理念,与国内外众多知名高校、研究机构和科学家团队建立了广泛的合作关系,在智慧医疗和健康养老领域持续创新和产业化应用。目前,拥有院士工作站、博士后工作站、博士工作站;核心科学家包括诺奖科学家2名、中外院士5名、教授10名、博士28名和研发人员200余名。

目前,易特科在“AI+医疗+健康+养老”领域已申请/拥有各类知识产权3000多项,是国家、广东省和深圳市知识产权优势企业、广东省知识产权示范企业,并获得了四项中国专利优秀奖,在智慧医疗细分领域专利申请数量国内第一、世界第四,四家子公司入选2018中国企业PCT国际专利申请排行榜TOP100;已获得ISO9001质量体系认证、美国软件工程学会CMMI3认证、信息系统集成及服务企业三级资质;是国家级智慧健康养老应用试点示范企业、国家工信息部医疗大数据产业发展试点示范企业,广东省健康管理互联网工程技术研究中心、广东省慢性病大数据工程技术研究中心和广东省医疗大数据示范基地;并获得中国互联网+医疗健康领军品牌、中国互联网+医疗健康最佳解决方案、中国智慧医疗行业领军企业、中国智慧医疗行业重质量、守诚信示范企业奖等荣誉。另外,国家各级主管部门授予易特科2018年广东省高成长中小企业、深圳市便利直通车服务企业、南山区绿色通道企业。

此外,凭借在生命IT、大健康和互联网医疗领域的杰出贡献,易特科集团董事长兼CEO张贯京先生获评2018中国智慧医疗行业领军人物、中国智慧医疗行业诚信企业家功勋奖、广东省特支计划科技创业领军人才等荣誉。

未来,易特科将以持续的创新能力、深厚的技术积累和优质的客户服务,打造“独角兽”硬科技高新技术企业,快速迈进IPO。

AI chronic disease intervention project of E-Techco (Qianhai AnyCheck) passed the inspection

 E-Techco (Qianhai AnyCheck) modern Chinese and Western medicine O2O chronic disease intervention technology and service operation project was officially approved by the expert group of the government science and technology department, which means E-Techco (Qianhai AnyCheck) successful completion of the research and development tasks, the realization of the main technical indicators, chronic disease management intervention technology once again received professional recognition, technology research and development strength to a new level.

The project will help medical institutions at all levels to establish and improve regional medical examination systems, regional health management systems, and regional chronic disease management systems to provide chronic disease health management services for key chronic-polluted populations and national residents. The results of the project will extend the application of modern Chinese and Western medicine O2O chronic disease intervention technology to the field of smart medicine, further improve the health monitoring, health assessment, health intervention ability and treatment level, and actively respond to China's major health problems and challenges, and promote comprehensive medical and health services. Coordinated sustainable development and promoted the construction of healthy China provided strong support.

Since its inception, E-Techco (Qianhai AnyCheck) has focused on health management, especially chronic disease management, and established a dedicated R&D team to cooperate with research institutes such as Hainan Medical College, Southern Medical University and Dublin City University. Under the guidance of Academician Yao Jianquan, focusing on the disease assessment model and big data analysis, the Anycheck Health Management Cloud Platform was established to explore the innovative model of smart healthcare through AI empowerment.

In recent years, under the leadership of the National Health and Health Commission, the Municipal Party Committee and the Municipal Government, and the Shenzhen Science and Technology Commission, E-Techco (Qianhai AnyCheck) has always adhered to the "technology-led and innovation-driven", giving play to the role of smart medical leading enterprises and bravely innovating. First, try first, continue to invest in information technology, biotechnology, digital technology and other fields, with the most advanced artificial intelligence, big data, deep learning and other technologies and products to serve the medical information and health care industry. In this regard, the project acceptance expert group gave full affirmation and high evaluation, and unanimously agreed that the project passed the inspection.

Brief Introduction of E-Techco Group:

E-Techco Group (Qianhai AnyCheck) is a high-tech enterprise in life IT technology research and product development. Since its establishment in 2003, E-Techco has been deeply rooted in the medical health industry, with cutting-edge technology research and innovation as its core development strategy, focusing on corporate culture and brand building, and continuing to invest in information technology, biotechnology, digital technology and other fields. It uses the most advanced AI, big data, deep learning and other technologies and products to serve medical informationization and health care industry.

E-Techco Group is located in Shenzhen Nanshan S&T Park Digital Technology Park, with branches in Beijing, Shanghai, Guangzhou, Tianjin, Xi'an, Shijiazhuang, Fuzhou, Shenyang, Changsha and Guilin. And overseas branches are in Hong Kong, Silicon Valley, Europe, Ireland and Finland, etc. At present, products and solutions of company such as medical intelligence, intelligent testing equipment, medical informationatization, health informationatization, and regional health informationatization have been selected into the catalogue of promoted product from the Ministry of Industry and Information Technology of China, and are widely used in more than 650 top three hospitals, 450 social health centers and health management centers. The products have received positive response and wide acclaim from the market.

Over the years, E-Techco has been adhering to the business philosophy of “Innovation-driven and technology-led”, and has established extensive cooperative relationships with many well-known universities, research institutes and scientists at home and abroad, and continues to innovate and industrialize in the fields of smart medical care and healthy retirement. application. At present, there are academician workstations, postdoctoral workstations, and doctoral workstations; core scientists include 2 Nobel Prize scientists, 5 Chinese and foreign academicians, 10 professors, 28 doctors, and more than 200 research and development personnel.

At present, E-Techco has applied/owned over 3,000 kinds of intellectual property rights in the field of “AI+ Medical+ Health+ Elderly Care”. It has honored Intellectual Property Advantage Enterprise of China, Guangdong Province and Shenzhen. It also has achieved demonstration enterprise of intellectual property rights of Guangdong Province. Besides, it achieved four China Patent Excellence Awards, and the number of patent applications in the field of smart medical segment ranked first in the country and fourth in the world. Four subsidiaries of group are selected as TOP100 in the PCT international patent application list of 2018 Chinese enterprises. It has obtained ISO9001 quality system certification and US software engineering CMMI3 certification, information system integration and service enterprise three-level qualification. It is a national-level smart health elderly care application pilot model enterprise, the National Ministry of Industry and Information Technology medical big data industry development pilot model enterprise, Guangdong Province Health Management Internet Engineering Technology Research Center, Guangdong Province Chronic Disease Big Data Engineering Technology Research Center and Guangdong Medical Data Demonstration Base and won the Chinese Internet + medical health leading brand, China Internet + medical health best solution, China's smart medical industry leader, China's smart medical industry, quality, Honor in honor of the Demonstration Enterprise Award. In addition, the competent authorities at all levels of the state granted E-Techco's 2018 Guangdong high-growth SMEs, Shenzhen's convenient through-train service enterprises, and Nanshan District Green Passage Enterprise.

In addition, with outstanding contributions in life IT, health and Internet medical, Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, was awarded the 2018 China Smart Healthcare Industry Leader, China Smart Healthcare Industry Honest Entrepreneur Meritorious Award, Guangdong Province Special Honoring the talents of planning, technology, entrepreneurship and leading talents.

In the future, E-Techco will build an “unicorn” hard technology high-tech enterprise with continuous innovation capability, deep technical accumulation and high-quality customer service, and is preparing for the process of IPO.